The primary goals of this randomized controlled trial are to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle intervention to reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women with a history of abnormal glucose tolerance during pregnancy.
Program Impact Region:
Program identifies community participants.
Program Start (and End Dates):
September 3, 2012 to June 30, 2017
Baystate Medical Center
Springfield, MA 01199United States
UMASS Medical Center
Worcester, MA 01655United States
Program Director's Email Address:
Megan Ward Harvey
UNIT: Colleges, Schools, Departments, Centers, and Institutes:
School of Public Health and Health Sciences/Epidemiology
This Project Receives External Funding: